Lauren Biscaldi is the Managing Editor of Drug Topics.
News Roundup: March 7 to March 11
Your weekly roundup of the latest news from Drug Topics®.
Drug Topics® Responds: AMA Statement on Test to Treat Initiative
The AMA objects to pharmacy-based clinics as an access point for COVID-19 treatments.
Is Automated Prescription Pickup the Future of Pharmacy?
Script Center kiosks are an ATM and an Amazon locker rolled into one.
News Roundup: February 28 to March 4
mRNA Vaccine Technology Update
Multiple pharmaceutical companies are investigating the application of mRNA technology to develop vaccines that treat and prevent multiple conditions, from influenza to cancer and beyond.
“Smart” Therapeutics Create Ethical Conundrums
With each new technological advance comes a set of potential downsides and a myriad of ethical dilemmas that must be addressed.
This Week in COVID-19: Latest on New CDC Guidance
COVID-19 updates and news to know as of February 28, 2022.
March 2022: In This Issue
A look at what’s to come in the March issue of Drug Topics®
February Month in Review: Top Stories This Month on Drug Topics®
Take a look back at our most popular news from February 2022.
News Roundup: February 21 to February 25
AbbVie Submits Supplemental NDA for Vraylar for Adjunctive MDD Therapy
Cariprazine is already approved to treat schizophrenia and bipolar I in adults.
This Week in COVID-19: As New Omicron Variant Circulates, States Lift Mask Mandates
COVID-19 updates and news to know as of February 21, 2022.
News Roundup: February 11 to February 18
Novavax Announces Positive Results of Pediatric Trial for COVID-19 Vaccine Candidate
NVX-CoV2373 was evaluated in adolescents aged 12 to 17 years.
News Roundup: February 7 to February 11
This Week in COVID-19: Pandemic Death Toll Reaches Grim Milestone
COVID-19 updates and news to know as of February 7, 2022.
Navigating Health Care as a Transgender Patient
A recent episode of Medical World News' Deep Dive shared best practices for caring for transgender patients.
News Roundup: January 31 to February 4
February 2022: In This Issue
A look at what’s to come in the February issue of Drug Topics®.
Breaking: Novavax Submits EUA Request for COVID-19 Vaccine Candidate
NVX-CoV2373 is a protein-based COVID-19 vaccine for adults 18 years and older.
This Week in COVID-19: As Omicron Cases Slow, New Subvariant Is Identified
COVID-19 updates and news to know as of January 31, 2022.
January Month in Review: Top Stories This Month on Drug Topics®
Take a look back at our most popular news from January 2022.
COVID-19: Endorsement of Vaccine Misinformation Associated With Depression Symptoms
Further research is needed to determine causation.
Sotrovimab Joins the WHO List of Potential COVID-19 Treatments
The monoclonal antibody was conditionally recommended for the treatment of mild to moderate COVID-19 in patients at high risk of hospitalization.
This Week in COVID-19: A Patent-Free COVID-19 Vaccine May Be On The Horizon
COVID-19 updates and news to know as of January 17, 2022.
This Week in COVID-19: Biden Administration Vaccine Mandate Goes Into Effect
COVID-19 updates and news to know as of January 11, 2022.
2021 Pharmacy Award Winners, the Best of the Best
Four winners of the SingleCare Best of the Best Pharmacy Awards joined Drug Topics® to share their knowledge with fellow pharmacists and pharmacy technicians.
This Week in COVID-19: Omicron Spike Leads to Record Case Count
COVID-19 updates and news to know as of January 3, 2022.
This Week in COVID-19: Case Rate Doubling at a Rapid Pace
COVID-19 updates and news to know as of December 20, 2021.
Year in Review: 2021 Top Podcasts from Drug Topics®
Take a look back at the top podcasts published on Drug Topics® this year.